Viewing nowLosatin Tablet 100 mg (Losartan Potassium)
Losartan Potassium 100mg
Tablet · Prescription medication
Baskan Bio Pharmaceuticals Co., Ltd.

MFDS item code 201704862 · Approved 2017.06.29
Treatment of hypertension and nephropathy in patients with type 2 diabetes accompanied by hypertension
This medication is used to treat hypertension. It also helps in preventing and managing the progression of kidney disease in patients with hypertension and type 2 diabetes, thus effectively controlling blood pressure and protecting kidney function.
This medicine may be taken regardless of meals, but it is recommended that it be taken at the same time each day. Hypertension (adults): The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, increased to 100 mg once daily. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used blood glucose-lowering agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Older adults: No adjustment of the initial dose is necessary in older adults aged 75 years or younger. For those over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment: Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Patients with renal impairment: Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with reduced effective intravascular volume: An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics) (see the Precautions for Use section). Patients with hepatic impairment: A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with other antihypertensive agents (e.g., low-dose diuretics). An additive effect was observed when administered concomitantly with hydrochlorothiazide.
Children and adolescents aged 6 years and older weighing ≥ 20 kg and < 50 kg who can swallow tablets: The recommended dose is 25 mg of this medicine once daily, and may be increased to a maximum of 50mg once daily depending on the patient’s blood pressure response. Children and adolescents aged 6 years and older weighing ≥ 50 kg: The usual recommended dose is 50 mg of this medicine once daily, and may be increased to a maximum of 100 mg once daily depending on the patient’s blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medicine may cause serious harm to the fetus if taken during pregnancy, especially in the 2nd and 3rd trimesters. Therefore, women who are pregnant or may become pregnant should not take this medication. If pregnancy is confirmed, this medication should be stopped immediately. This medication should not be given to patients with certain conditions, such as severe liver impairment or a history of hereditary angioedema, and to patients with specific genetic lactose intolerance. Additionally, caution should be exercised when combining this medication with other drugs in patients with diabetes or moderate to severe kidney impairment. This medication should be used cautiously in certain patients, such as the elderly, those with hyperkalemia, patients with mild to moderate liver impairment, and those with heart valve disease, as there is a risk of excessively low blood pressure or worsening kidney function. Their condition should be monitored frequently. Although this medication is generally well tolerated, rare adverse reactions such as angioedema, liver function abnormalities, myalgia, and hyperkalemia may occur; so any unusual symptoms should be discussed with a healthcare provider immediately. It is important to regularly check blood pressure, kidney function, and electrolyte levels during use to confirm normality. This medication may dangerously increase blood potassium levels if taken with potassium-sparing diuretics or potassium supplements, so caution should be taken to avoid such combinations. When used with non-steroidal anti-inflammatory drugs, the blood pressure-lowering effect may be reduced or kidney function may deteriorate, so careful monitoring is necessary. It is advisable for pregnant or breastfeeding women to refrain from taking this medication, and if breastfeeding, to consider stopping breastfeeding or alternative treatments. This medication has not been established as safe and effective in children, particularly those under 6 years old or with significantly reduced kidney function. During treatment, caution should be exercised with tasks that require alertness, such as operating machinery or driving, as dizziness or drowsiness may occur. In case of overdose, hypotension and cardiac arrhythmias may occur, so it's important to adhere strictly to the prescribed dosage and to seek medical attention immediately if unusual symptoms arise. Lastly, this medication should be stored out of reach of children, and not transferred to other containers for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. The storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature. Storing it this way can help maintain the medication's effectiveness and safety for a long time.
White, drop-shaped film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 100mg
Tablet · Prescription medication
Baskan Bio Pharmaceuticals Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.